SNOA

Sonoma Pharmaceuticals, Inc. Common Stock

3.67

USD

SNOA Earnings Reports

Positive Surprise Ratio

SNOA beat 11 of 21 last estimates.

52%

Next Report

Date of Next Report

Feb 03, 2026

Estimate for Q3 26 (Revenue/ EPS)

$4.41M

-$0.31

Implied change from Q2 26 (Revenue/ EPS)

-21.26%

-3.13%

Implied change from Q3 25 (Revenue/ EPS)

+23.81%

-50.79%

Sonoma Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, SNOA reported earnings of -0.32 USD per share (EPS) for Q2 26, missing the estimate of -0.31 USD, resulting in a -1.20% surprise. Revenue reached 5.60 million, compared to an expected 4.35 million, with a 28.94% difference. The market reacted with a -0.53% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 4.41 million USD, implying an decrease of -3.13% EPS, and decrease of -21.26% in Revenue from the last quarter.

FAQ

What were Sonoma Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Sonoma Pharmaceuticals, Inc. Common Stock reported EPS of -$0.32, missing estimates by -1.2%, and revenue of $5.60M, 28.94% above expectations.

How did the market react to Sonoma Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -0.53%, changed from $3.78 before the earnings release to $3.76 the day after.

When is Sonoma Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 03, 2026.

What are the forecasts for Sonoma Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 3 analysts, Sonoma Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of $4.41M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.